AllianceBernstein
JNP

AllianceBernstein’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

AllianceBernstein’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-73
Closed -$1K – 3758
2014
Q1 		$1K Hold
73
– – ﹤0.01% 3591
2013
Q4 		$0 Hold
73
– – ﹤0.01% 3502
2013
Q3 		$1K Buy
+73
New +$491 ﹤0.01% 3415

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's JNP Position: Q2 2014 in Review

AllianceBernstein sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2014, closing a stake of 73 shares — an estimated $1K sold.

AllianceBernstein first reported a position in JNP in Q3 2013 and held it in 3 quarters. The position peaked at $1K in Q1 2014. 38 funds tracked by Wall St. Rank hold JNP as of Q2 2014.

  • AllianceBernstein reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • AllianceBernstein sold 73 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2014, an estimated $1K.
  • AllianceBernstein first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • AllianceBernstein's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.